Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Li Huang
Shanghai Jiao Tong University (SJTU)
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
76
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Serum AKR1B10 is a Promising Biomarker for Early-Stage and CA19-9-Negative Pancreatic Ductal Adenocarcinoma: A Prospective Multicenter Study
Number of pages: 20
Posted: 03 Dec 2024
Zhongyi Jiang
,
Pusen Wang
,
Yao Meng
,
Rulin Zhang
,
Wei-Tao Que
,
Qianwei Jiang
,
Haitao Gu
, Li Huang,
Baiwen Li
,
Guo Wen-Zhi
,
Guoyue Lv
,
Tianlin He
,
Hao Li
and
Lin Zhong
Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Naval Medical University, Shanghai Jiao Tong University (SJTU), Zhengzhou University - Department of Hepatobiliary and Pancreatic Surgery, Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Zhengzhou University - Department of Hepatobiliary and Pancreatic Surgery, Jilin University (JLU) - Department of Hepatobiliary-Pancreatic Surgery, Naval Medical University, Shanghai Jiao Tong University (SJTU) - Department of General Surgery and Shanghai Jiao Tong University (SJTU) - Department of General Surgery
Downloads
76
(830,555)
View PDF
Download
Abstract:
AKR1B10, CA19-9, Pancreatic Ductal Adenocarcinoma, Biomarker, Serological Diagnosi
Feedback
